Medaphor Group PLC Opening of Hong Kong office (4502F)
February 21 2018 - 1:00AM
UK Regulatory
TIDMMED
RNS Number : 4502F
Medaphor Group PLC
21 February 2018
MedaPhor Group plc
("MedaPhor" or the "Group" or the "Company")
Opening of Hong Kong office
MedaPhor Group plc (AIM: MED), the intelligent ultrasound
software and simulation company, announces that it has opened an
office in Hong Kong to facilitate the Group's established reseller
network and growing customer base in the Asia-Pacific (APAC)
region.
The Group now has 18 active reseller partners in this region
selling the ScanTrainer, HeartWorks and new BodyWorks Eve
simulation portfolio into hospitals and university teaching
schools.
The new Hong Kong office will support and aim to expand reseller
sales, marketing and customer relations across the APAC region and
especially in the growing Chinese simulation market.
The Company has appointed a local Channel and Product Support
Manager, Victor Kwan, to be permanently based out of the Hong Kong
office. Victor brings with him over 10 years of experience working
in product marketing and management, seven of which were spent in
the medical simulation industry.
Stuart Gall, Chief Executive Officer at MedaPhor, comments:
"We now have a well-established reseller channel in APAC and are
looking to cement our presence in the region. With its central
location and excellent transport links, our new Hong Kong office
will enable us to have a full-time local presence in these
important and growing markets, as we look to continue the expansion
and growth in the APAC ultrasound software and simulation
market."
Enquiries:
MedaPhor Group plc investors.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075
Ian Whittaker, COO 6534
Cenkos Securities Tel: +44 (0)20 7397
8900
Camilla Hume/Bobbie Hilliam
(Nominated Advisor)
Michael Johnson / Julian
Morse (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780 or
medaphor@walbrookpr.com
Paul McManus / Anna Mob: +44 (0)7980 541 893 / Mob:
Dunphy +44 (0)7876 741 001
About MedaPhor (investors.medaphor.com)
MedaPhor (AIM: MED), the intelligent ultrasound software and
simulation company, develops artificial intelligence-based clinical
image analysis software tools, augmented reality-based needle
guidance software and advanced hi-fidelity haptic and manikin-based
training simulators for medical practitioners.
Based in Cardiff and Oxford in the UK and Atlanta in the US,
MedaPhor is split into two divisions:
Intelligent Ultrasound Simulation and Training
Focuses on hi-fidelity ultrasound education and training through
simulation. Its three main products are the ScanTrainer OBGYN and
General Medical simulator training platform, the HeartWorks
Echocardiography simulator platform and BodyWorks Eve the Point of
Care Ultrasound (PoCUS) simulator. Over 500 MedaPhor simulators
have been sold to over 300 medical institutions in over 30
countries around the world.
Intelligent Ultrasound Clinical Support
Focuses on augmented reality and deep-learning based algorithms
to make ultrasound machines smarter and more accessible. Products
in development include ScanNav which uses machine-learning based
algorithms to automatically identify and grade ultrasound images to
provide scan assessment and audit of obstetric scanning.
NeedleGuide aims to simplify ultrasound-guided needling by using
deep learning and augmented reality to provide the user with
pathway guidance and automated tracking for a range of medical
procedures.
Some products in the pipeline may require US FDA approval, as
such this material should be considered informational only and does
not constitute an offer to sell, or infer, claims or benefits.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDBLFLVLFXBBK
(END) Dow Jones Newswires
February 21, 2018 02:00 ET (07:00 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Jul 2024 to Aug 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Aug 2023 to Aug 2024
